share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：拟议出售证券
美股sec公告 ·  07/09 16:32
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company on 07/09/2024, with an aggregate market value of $109,777.31. The shares were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with a cash payment made on the same date. This planned transaction follows a series of sales over the past three months, where a total of 78,124 shares were sold for gross proceeds of $645,887.34.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company on 07/09/2024, with an aggregate market value of $109,777.31. The shares were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with a cash payment made on the same date. This planned transaction follows a series of sales over the past three months, where a total of 78,124 shares were sold for gross proceeds of $645,887.34.
Recursion Pharmaceuticals公司官员Secora Michael计划于2024年07月09日卖出公司的15000股A类股票，总市值为$109,777.31。这些股票最初是在2023年06月13日通过股票期权行使从发行人手中获得的，当日付现金。这次计划交易是在过去三个月中一系列销售交易之后进行的，总共售出78124股，总收入为$645,887.34。
Recursion Pharmaceuticals公司官员Secora Michael计划于2024年07月09日卖出公司的15000股A类股票，总市值为$109,777.31。这些股票最初是在2023年06月13日通过股票期权行使从发行人手中获得的，当日付现金。这次计划交易是在过去三个月中一系列销售交易之后进行的，总共售出78124股，总收入为$645,887.34。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息